[go: up one dir, main page]

MX2018004143A - Composicion que comprende niacinamida y picolinamida. - Google Patents

Composicion que comprende niacinamida y picolinamida.

Info

Publication number
MX2018004143A
MX2018004143A MX2018004143A MX2018004143A MX2018004143A MX 2018004143 A MX2018004143 A MX 2018004143A MX 2018004143 A MX2018004143 A MX 2018004143A MX 2018004143 A MX2018004143 A MX 2018004143A MX 2018004143 A MX2018004143 A MX 2018004143A
Authority
MX
Mexico
Prior art keywords
picolinamide
niacinamide
composition
topical composition
present
Prior art date
Application number
MX2018004143A
Other languages
English (en)
Inventor
Majumdar Amitabha
Swamy Mathapathi Mruthyunjaya
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of MX2018004143A publication Critical patent/MX2018004143A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición tópica y más particularmente una composición tópica para beneficio antimicrobiano. De acuerdo con la presente invención, se proporciona una composición tópica que comprende niacinamida y picolinamida en donde la proporción molar de niacinamida a picolinamida es de 1:20 a 20:1.
MX2018004143A 2015-10-05 2016-10-04 Composicion que comprende niacinamida y picolinamida. MX2018004143A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15188360 2015-10-05
PCT/EP2016/073626 WO2017060213A1 (en) 2015-10-05 2016-10-04 Composition comprising niacinamide and picolinamide

Publications (1)

Publication Number Publication Date
MX2018004143A true MX2018004143A (es) 2018-06-13

Family

ID=54256684

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018004144A MX365369B (es) 2015-10-05 2016-10-04 Una composición para aclarar la piel.
MX2018004143A MX2018004143A (es) 2015-10-05 2016-10-04 Composicion que comprende niacinamida y picolinamida.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018004144A MX365369B (es) 2015-10-05 2016-10-04 Una composición para aclarar la piel.

Country Status (13)

Country Link
US (3) US10660840B2 (es)
EP (2) EP3359124B1 (es)
JP (2) JP6907196B2 (es)
KR (1) KR102643373B1 (es)
CN (2) CN108135824B (es)
AR (1) AR106261A1 (es)
BR (1) BR112018005742B1 (es)
CA (2) CA3000296A1 (es)
EA (2) EA035440B1 (es)
MX (2) MX365369B (es)
PH (1) PH12018500619A1 (es)
WO (2) WO2017060213A1 (es)
ZA (2) ZA201802005B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3359124B1 (en) * 2015-10-05 2020-06-03 Unilever NV Composition comprising niacinamide and picolinamide
EP3727315B1 (en) 2017-12-18 2021-10-13 Unilever Global IP Limited A topical composition comprising n-cyclopropyl nicotinamide
KR102883281B1 (ko) * 2018-11-09 2025-11-13 (주)아모레퍼시픽 색소 침착 모델 세포용 세포배양액, 이를 이용한 색소 침착 모델 세포, 색소 침착 모델 세포 제조방법, 색소 침착 모델 세포를 이용한 피부 미백 물질 스크리닝 방법 및 피부 미백용 조성물
KR102792650B1 (ko) * 2018-11-13 2025-04-08 (주)아모레퍼시픽 색소 침착 모델 세포용 세포배양액, 이를 이용한 색소 침착 모델 세포, 색소 침착 모델 세포 제조방법, 색소 침착 모델 세포를 이용한 피부 미백 물질 스크리닝 방법 및 피부 미백용 조성물
MX2022000347A (es) * 2019-07-12 2022-02-03 Unilever Ip Holdings B V Combinaciones bioenergeticas y metodos de uso del mismo.
WO2021249760A1 (en) * 2020-06-10 2021-12-16 Unilever Ip Holdings B.V. A cosmetic composition comprising 6-methyl-picolinamide
US11696889B2 (en) 2020-08-07 2023-07-11 David Levy Botanical antimicrobial composition
EP4326062A4 (en) * 2021-04-22 2025-02-19 Surgiwipe LLC TOPICAL ANTISEPTIC
JP2025508187A (ja) * 2022-03-18 2025-03-21 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ 皮膚ブライトニング組成物
WO2025228618A1 (en) * 2024-05-01 2025-11-06 Unilever Ip Holdings B.V. A personal care composition

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1370236A (en) * 1972-01-11 1974-10-16 Unilever Ltd Skin composition
GB1533119A (en) * 1975-04-10 1978-11-22 Unilever Ltd Skin lightening compositions
GB8910366D0 (en) * 1989-05-05 1989-06-21 Unilever Plc Skin composition
TW233264B (es) 1992-02-03 1994-11-01 Otsuka Pharma Co Ltd
US5411741A (en) 1993-07-29 1995-05-02 Zaias; Nardo Method and composition for skin depigmentation
WO1999047141A1 (en) 1998-03-16 1999-09-23 The Procter & Gamble Company Method of treating skin irritation
JP2003529590A (ja) 2000-03-21 2003-10-07 アスション デヴェロップメント エーピーエス ピリジンカルボキシ誘導体およびｈ２ヒスタミン受容体アンタゴニストからなる化学的複合体
US20030105034A1 (en) 2001-07-05 2003-06-05 Astion Deveopment A/S Pyridine carboxy derivatives and an aminosugar
FR2827763B1 (fr) 2001-07-24 2005-09-23 Cs Substance alkyloside inhibant la fixation de microorganismes, utilisation topique et composition contenant au moins une telle substance
JP3908969B2 (ja) * 2002-03-18 2007-04-25 ピアス株式会社 化粧料
ES2274236T3 (es) 2002-06-20 2007-05-16 Astion Dermatology A/S Complejos novedosos de esteres de acidos grasos de polihidroxialcanos y nacinamida.
JP2004123554A (ja) * 2002-09-30 2004-04-22 Pias Arise Kk 皮膚バリア機能改善物質、皮膚のしわ改善物質、および該物質を含む皮膚外用剤、化粧料および医薬部外品
US20090105188A1 (en) 2007-10-17 2009-04-23 Nationwide Children's Hospital, Inc. Compositions and Methods for Treating Necrotizing Enterocolitis
US20090317341A1 (en) 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
EP2313074A4 (en) 2008-06-30 2015-04-15 Elc Man Llc TOPICAL COMPOSITIONS CONTAINING ISONICOTINAMIDE
CN102209701B (zh) * 2008-11-11 2014-10-15 西格纳姆生物科学公司 异戊二烯基化合物和其方法
US20130052162A1 (en) 2010-04-20 2013-02-28 Cedars-Sinai Medical Center Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
EP2522331A1 (en) 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and niacinamide
WO2013030794A2 (en) * 2011-08-31 2013-03-07 Behrooz Kasraee Use of substituted pyridines as skin depigmenting compounds
US20140161750A1 (en) * 2012-12-12 2014-06-12 Thomas Christopher Balshi Sunscreen composition with pigment correcting properties
EP2742942B1 (en) * 2012-12-14 2019-05-22 Unilever N.V. Niacinamide for inducing generation of antimicrobial peptides
WO2015061512A1 (en) 2013-10-24 2015-04-30 The Procter & Gamble Company Skin lightening cosmetic compositions and methods
EA031758B1 (ru) 2014-05-12 2019-02-28 Юнилевер Н.В. Ниацинамид для стимуляции продуцирования антимикробных пептидов
EP3359124B1 (en) 2015-10-05 2020-06-03 Unilever NV Composition comprising niacinamide and picolinamide

Also Published As

Publication number Publication date
CN108136232A (zh) 2018-06-08
CN108135824A (zh) 2018-06-08
EA035789B1 (ru) 2020-08-11
MX365369B (es) 2019-05-31
WO2017060211A1 (en) 2017-04-13
US11298312B2 (en) 2022-04-12
BR112018005742B1 (pt) 2021-11-16
US10952952B2 (en) 2021-03-23
MX2018004144A (es) 2018-06-13
PH12018500619B1 (en) 2018-10-01
KR20180054647A (ko) 2018-05-24
CN108136232B (zh) 2021-08-13
US20180280278A1 (en) 2018-10-04
CN108135824B (zh) 2021-09-17
CA3000880A1 (en) 2017-04-13
WO2017060213A1 (en) 2017-04-13
EP3359124A1 (en) 2018-08-15
JP6880011B2 (ja) 2021-06-02
JP2018529735A (ja) 2018-10-11
ZA201802005B (en) 2019-07-31
EA035440B1 (ru) 2020-06-15
EP3359261B1 (en) 2019-05-15
EP3359261A1 (en) 2018-08-15
KR102643373B1 (ko) 2024-03-07
EA201890889A1 (ru) 2018-09-28
BR112018005742A2 (pt) 2018-10-09
EA201890886A1 (ru) 2018-09-28
AR106261A1 (es) 2017-12-27
US20200230045A1 (en) 2020-07-23
CA3000296A1 (en) 2017-04-13
US10660840B2 (en) 2020-05-26
ZA201802233B (en) 2019-07-31
JP2018529741A (ja) 2018-10-11
JP6907196B2 (ja) 2021-07-21
PH12018500619A1 (en) 2018-10-01
EP3359124B1 (en) 2020-06-03
US20180296457A1 (en) 2018-10-18

Similar Documents

Publication Publication Date Title
MX2018004143A (es) Composicion que comprende niacinamida y picolinamida.
AU2015207757A8 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2
IL266214B (en) 5,4,2-tri-converted 4,2,1-triazolones used as dhodh inhibitors
PH12019550235A1 (en) Kinase inhibitors and uses thereof
HK1245019A1 (zh) 吡啶酰胺化合物作爲杀真菌剂的用途
MX2018001045A (es) Compuestos de piridina utiles para combatir hongos fitopatogenos.
MX2017002969A (es) Composiciones detergentes que contienen un surfactante ramificado.
SG10201809518QA (en) Processes of preparing a jak1 inhibitor and new forms thereto
JO3466B1 (ar) مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
AU2014375265A1 (en) Novel pyrazolyl-heteroarylamides as pesticides
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
MX2018007418A (es) Compuestos de benzamida y sus usos como herbicidas.
AU2017317563A8 (en) Detergent compositions comprising xanthan lyase variants I
PH12017502051A1 (en) TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF
UA120058C2 (uk) Пестицидні композиції
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
MA39843A (fr) Pyridine-2-amides utiles comme agonistes de cb2
MX2019013419A (es) Compuestos plaguicidas biciclicos.
IN2015DN01688A (es)
EA033460B1 (ru) Замещенные [1,2,4]триазольные соединения в качестве фунгицидов
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MX2015008829A (es) Momelotinib deuterado.
EA201890186A1 (ru) Применение штаммов микробактерий для получения антибактериальных агентов
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MX2017002015A (es) Ligando del receptor 2 de canabinoide radiomarcado.

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: UNILEVER IP HOLDINGS B.V.